NCT03616886 2024-12-19
SYNERGY
Jules Bordet Institute
Phase 1/2 Active not recruiting
Clinical Trials
3 trialsNCT06508216 2024-07-22
COMPASS-TNBC
Gustave Roussy, Cancer Campus, Grand Paris
Phase 1/2 Recruiting
NCT02628132 2020-07-07
Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients
King Faisal Specialist Hospital & Research Center
Phase 1/2 Completed